Table 2.
Medical characteristics of the study populations (n = 218) (% unless marked otherwise)
| |
Natives |
Migrants |
|
||
|---|---|---|---|---|---|
| N | % | n | % | p-value | |
|
Diabetes type II |
134 |
100 |
81 |
96.4 |
0.056 |
|
Diabetes-related diseases |
65 |
48.5 |
26 |
31.0 |
0.011 |
| Polyneuropathy |
58 |
43.3 |
25 |
29.8 |
0.045 |
| Carotid artery disease |
28 |
20.9 |
18 |
21.4 |
0.925 |
| Nephropathy |
19 |
14.2 |
10 |
11.9 |
0.630 |
| Retinopathy |
10 |
7.5 |
4 |
4.8 |
0.574 |
| Diabetic feet syndrome |
9 |
6.7 |
2 |
2.4 |
0.210 |
| Renal insufficiency |
6 |
4.5 |
9 |
10.7 |
0.077 |
| Coronary disease |
37 |
27.6 |
12 |
14.3 |
0.022 |
| Past myocardial infarction |
20 |
14.9 |
10 |
11.9 |
0.529 |
| Coronary artery bypass |
8 |
6.0 |
3 |
3.6 |
0.536 |
| Peripheral vascular disease |
13 |
9.7 |
7 |
8.3 |
0.733 |
|
Other stroke risk factors |
|
|
|
|
|
| Hypertension |
124 |
92.5 |
63 |
75.0 |
<0.001 |
| Atrial fibrillation |
10 |
7.5 |
2 |
2.4 |
0.135 |
| Hyperlipidemia |
71 |
53.0 |
36 |
42.9 |
0.145 |
| Current smoker |
24 |
17.9 |
23 |
27.4 |
0.098 |
| Former smoker |
6 |
4.5 |
16 |
19.0 |
0.001 |
| Obesity with BMI ≥30 |
73 |
54.5 |
53 |
63.1 |
0.210 |
| Regular alcohol intake |
4 |
3.0 |
0 |
0.0 |
0.301 |
| Prior stroke |
18 |
13.4 |
9 |
10.7 |
0.553 |
| Oral contraceptive |
1 |
0.7 |
6 |
7.1 |
0.014 |
| Family history of stroke |
17 |
12.7 |
22 |
26.2 |
0.011 |
|
Diabetes therapy |
|
|
|
|
|
| Participant in disease management program |
134 |
100 |
84 |
100 |
|
| Dietary therapy only |
47 |
35.1 |
26 |
31.0 |
0.530 |
| Metformin |
72 |
53.7 |
50 |
59.5 |
0.402 |
| Insulin therapy |
31 |
23.1 |
19 |
22.6 |
0.930 |
| Years in practice, average (span), yrs |
13.5 (1–36) |
19.0 (1–40) |
<0.001 |
||
| Practice contacts in last year, average (span), n |
10.4 (1–21) |
9.4 (1–23) |
0.109 |
||
| HbA1c, average (SD),% |
6.9 (5.0-13.7) |
7.3 (5.4-12.4) |
0.319 |
||
| LDL, average (SD), mg/dl |
128 (37–260) |
122 (32–233) |
0.098 |
||
| Blood pressure, average, mmHg | 140/79 | 136/80 | 0.409 | ||